Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02683993 · ClinicalTrials.gov registry record · NA

Utilizing Holmium Laser for FURS Renal Stone Lithotripsy Comparing Stone Breaking vs. Stone Dusting Settings

A NA study, sponsored by Boston Scientific Corporation.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT02683993: Completed NA study, sponsored by Boston Scientific Corporation.

NCT02683993 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02683993, a NA study, has completed, sponsored by Boston Scientific Corporation.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

Twenty (20) subjects presenting with a renal stone and candidates for FURS (flexible ureteroscopic renal surgery) will undergo a single FURS procedure for a kidney stone as part of the study, using the study device. These subjects will be randomized into stone breaking treatment or stone dusting.

Primary Outcome

stone clearance will be confirmed by CT or X-Ray at 1 month follow up.

Interventions

  • DEVICE Lumenis Pulse 120H holmium laser system and 200 DFL ball tip fiber

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2016-02
Est. Completion 2017-01-31
Phase NA
Boston Scientific Corporation

280 total trials

What the finished NCT02683993 record still lists

NCT02683993 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Lumenis Pulse 120H holmium laser system and 200 DFL ball tip fiber is the first listed.

NCT02683993 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02683993 about?

NCT02683993 is a clinical study titled "Utilizing Holmium Laser for FURS Renal Stone Lithotripsy Comparing Stone Breaking vs. Stone Dusting Settings". Twenty (20) subjects presenting with a renal stone and candidates for FURS (flexible ureteroscopic renal surgery) will undergo a single FURS procedure for a kidney stone as part of the study, using the study device. These subjects will be randomized into stone breaking treatment or stone dusting.

What is the current status of trial NCT02683993?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2016-02. Estimated completion is 2017-01-31.

What interventions are being tested in trial NCT02683993?

The interventions under investigation include: Lumenis Pulse 120H holmium laser system and 200 DFL ball tip fiber (DEVICE).

Who is sponsoring clinical trial NCT02683993?

This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02683993's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02683993, the US trial registry maintained by the National Library of Medicine. NCT02683993 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.